From: High dose simultaneous integrated boost for node positive cervical cancer
EBCRT with SIB (n = 23) | EBCRT without SIB (n = 46) | EBCRT with SIB (n = 23) | EBCRT without SIB (n = 46) | |
---|---|---|---|---|
Acute GI toxicities (%) | Acute GU toxicities (%) | |||
Grade 0 | 70 | 56 | 88 | 78 |
Grade 1 | 22 | 33 | 4 | 22 |
Grade 2 | 8 | 11 | 8 | 0 |
Grade 3 | 0 | 0 | 0 | 0 |
Grade 4 | 0 | 0 | 0 | 0 |
Grade 5 | 0 | 0 | 0 | 0 |
Late GI toxicities (%) | Late GU toxicities (%) | |||
Grade 0 | 69 | 52 | 65 | 72 |
Grade 1 | 5 | 33 | 5 | 24 |
Grade 2 | 26 | 11 | 30 | 4 |
Grade 3 | 0 | 0 | 0 | 0 |
Grade 4 | 0 | 2 | 0 | 0 |
Grade 5 | 0 | 2 | 0 | 0 |
Fatigue (%) | Vaginal stenosis (%) | |||
Grade 0 | 62 | 63 | 27 | 29 |
Grade 1 | 30 | 33 | 42 | 50 |
Grade 2 | 8 | 4 | 26 | 17 |
Grade 3 | 0 | 0 | 5 | 4 |
Grade 4 | 0 | 0 | 0 | 0 |
Grade 5 | 0 | 0 | 0 | 0 |
Lymphoedema (%) | Pelvic fracture (%) | |||
Grade 0 | 79 | 94 | 95 | 85 |
Grade 1 | 17 | 4 | 5 | 11 |
Grade 2 | 4 | 2 | 0 | 4 |
Grade 3 | 0 | 0 | 0 | 0 |
Grade 4 | 0 | 0 | 0 | 0 |
Grade 5 | 0 | 0 | 0 | 0 |